IP Library › Assignment 047681/0466
Patent Assignment
Reel/Frame 047681/0466

Assignment of Assignor's Interest

Recorded: 2018-12-05 Pages: 18
Assignor
ALLERGAN, INC.
Executed: 2018-11-30
Assignee
ACLARIS THERAPEUTICS, INC.
640 LEE ROAD, SUITE 200, WAYNE, PENNSYLVANIA, 19087
Covered Properties (24)
Compositions and Methods for Treating Purpura
Pharmaceutical Cream Compositions and Methods of Use
Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
Gel Compositions of Oxymetazoline and Methods of Use
Stabilized Oxymetazoline Formulations and Their Uses
Compositions and Methods for Treating Purpura
Patent: 8,114,898 →
Application: 12/272,253 →
Publication: US 2009/0130027
Pharmaceutical Cream Compositions and Methods of Use
Patent: 8,883,838 →
Application: 13/309,403 →
Publication: US 2012/0149748
Compositions and Methods for Treating Purpura
Patent: 8,673,953 →
Application: 13/345,472 →
Publication: US 2012/0177585
Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
Application: 13/396,165 →
Publication: US 2012/0208858
Gel Compositions of Oxymetazoline and Methods of Use
Application: 13/548,009 →
Publication: US 2013/0079379
Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
Application: 14/144,106 →
Publication: US 2014/0113947
Compositions and Methods for Treating Purpura
Patent: 9,265,761 →
Application: 14/181,706 →
Publication: US 2014/0161749
Compositions and Methods for Treating Purpura
Application: 14/505,100 →
Publication: US 2015/0018358
Pharmaceutical Cream Compositions and Methods of Use
Application: 14/521,094 →
Publication: US 2015/0045403
Stabilized Oxymetazoline Formulations and Their Uses
Patent: 9,801,857 →
Application: 14/737,360 →
Publication: US 2015/0359781
Stabilized Oxymetazoline Formulations and Their Uses
Patent: 9,974,773 →
Application: 15/429,873 →
Publication: US 2017/0151217
Stabilized Oxymetazoline Formulations and Their Uses
Application: 15/984,918 →
Publication: US 2018/0263962
Compositions and methods of treating purpura
Application: 60/988,564 →
Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
Application: 61/419,693 →
Cream Compositions and Methods of Use
Application: 61/419,697 →
Pharmaceutical Cream Compositions of Oxymetazoline and Methods of Use
Application: 61/443,210 →
Gel Compositions of Oxymetazoline and Methods of Use
Application: 61/507,926 →
Oxymetazoline Cream for the Treatment of Erythema Associated with Rosacea
Application: 62/010,838 →
Stabilized Oxymetazoline Formulations and Their Uses
Application: 62/069,624 →
Related Assignments (9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 10, 2017
From: SARPOTDAR, PRAMOD; WARNER, KEVIN; AHLUWALIA, GURPREET; KUANG, AMY
To: ALLERGAN, INC.
Reel/Frame 041227/0329 →
Assignment of Assignor's Interest May 21, 2018
From: SARPOTDAR, PARMOD; WARNER, KEVIN; AHLUWALIA, GURPREET; KUANG, AMY
To: ALLERGAN, INC.
Reel/Frame 045862/0849 →
Assignment of Assignor's Interest Nov 1, 2019
From: ACLARIS THERAPEUTICS, INC.
To: EPI HEALTH, LLC
Reel/Frame 050905/0290 →
Security Interest Mar 14, 2022
From: EPI HEALTH, LLC
To: EVENING POST GROUP, LLC
Reel/Frame 059364/0509 →
Release of Security Interest Jan 11, 2023
From: EVENING POST GROUP, LLC
To: EPI HEALTH, LLC
Reel/Frame 062347/0129 →
Assignment of Assignor's Interest Dec 11, 2024
From: SARPOTDAR, PRAMOD; WARNER, KEVIN; AHLUWALIA, GURPREET; KUANG, AMY
To: ALLERGAN, INC.
Reel/Frame 069557/0245 →
Assignment of Assignor's Interest Dec 11, 2024
From: ACLARIS THERAPEUTICS, INC.
To: EPI HEALTH, LLC
Reel/Frame 069599/0614 →
Assignment of Assignor's Interest Dec 11, 2024
From: EPI HEALTH, LLC
To: MAYNE PHARMA LLC
Reel/Frame 069557/0372 →
Assignment of Assignor's Interest Dec 11, 2024
From: ALLERGAN, INC.
To: ACLARIS THERAPEUTICS, INC.
Reel/Frame 069557/0318 →